- Home
- ALVR vs OSTX Comparison
ALVR vs OSTX Comparison
Compare ALVR & OSTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALVR
- OSTX
- Stock Information
- Founded
- ALVR 2013
- OSTX 2018
- Country
- ALVR United States
- OSTX United States
- Employees
- ALVR N/A
- OSTX N/A
- Industry
- ALVR Biotechnology: Biological Products (No Diagnostic Substances)
- OSTX
- Sector
- ALVR Health Care
- OSTX
- Exchange
- ALVR Nasdaq
- OSTX NYSE
- Market Cap
- ALVR 48.8M
- OSTX 39.1M
- IPO Year
- ALVR 2020
- OSTX 2024
- Fundamental
- Price
- ALVR $9.63
- OSTX $1.70
- Analyst Decision
- ALVR
- OSTX Strong Buy
- Analyst Count
- ALVR 0
- OSTX 2
- Target Price
- ALVR N/A
- OSTX $17.50
- AVG Volume (30 Days)
- ALVR 22.4K
- OSTX 2.3M
- Earning Date
- ALVR 03-14-2025
- OSTX 03-04-2025
- Dividend Yield
- ALVR N/A
- OSTX N/A
- EPS Growth
- ALVR N/A
- OSTX N/A
- EPS
- ALVR N/A
- OSTX N/A
- Revenue
- ALVR N/A
- OSTX N/A
- Revenue This Year
- ALVR N/A
- OSTX N/A
- Revenue Next Year
- ALVR N/A
- OSTX $26,663.99
- P/E Ratio
- ALVR N/A
- OSTX N/A
- Revenue Growth
- ALVR N/A
- OSTX N/A
- 52 Week Low
- ALVR $7.96
- OSTX $1.58
- 52 Week High
- ALVR $24.15
- OSTX $7.00
- Technical
- Relative Strength Index (RSI)
- ALVR 45.63
- OSTX N/A
- Support Level
- ALVR $9.55
- OSTX N/A
- Resistance Level
- ALVR $10.41
- OSTX N/A
- Average True Range (ATR)
- ALVR 0.44
- OSTX 0.00
- MACD
- ALVR 0.05
- OSTX 0.00
- Stochastic Oscillator
- ALVR 22.77
- OSTX 0.00
About ALVR AlloVir Inc.
AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy platform enables the creation of off-the-shelf VSTs, addressing the urgent medical need for treating patients with limited viral disease treatment options. With a singular focus on research, development, and commercialization, the company's platform targets 11 devastating viruses, with posoleucel being the lead candidate addressing six viruses. Operating within one segment, the company is dedicated to preventing and treating severe viral-associated diseases through off-the-shelf VST therapies.
About OSTX OS THERAPIES INCORPORATED
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the significant need for new treatments in cancers of the bone in children and young adults.